At ImageBloom, we’ve seen firsthand how technology is reshaping the clinical trial landscape. Artificial Intelligence (AI) holds enormous promise in patient recruitment, and we leverage it every day to improve efficiency, precision, and scale. But while AI can accelerate parts of the recruitment journey, it can’t replace the human expertise, empathy, and creativity that drive
If you’ve turned on the TV, scrolled through social media, or flipped through a magazine lately, chances are you’ve seen an ad for a prescription drug. Hello Serena Williams and the latest GLP—1 controversy. This type of promotion—known as direct-to-consumer (DTC) pharmaceutical advertising—is designed to raise awareness, shape perceptions, and encourage patients to ask their
Conference season is a cornerstone of the clinical research industry, bringing together researchers, site staff, sponsors, CROs, and solution providers in one place. They provide a rare opportunity to exchange knowledge, discover new technologies, and build partnerships that advance clinical trials. At ImageBloom, Inc., we know that conference season is more than just a calendar
When it comes to clinical trial recruitment, success often hinges on the strength of your partnerships—especially with your recruitment vendors. Yet, many sponsors and CROs overlook critical questions that could make or break their enrollment timelines and overall trial success. If you’re vetting a recruitment partner—or already working with one—here are some key questions you
By Brandy Church, MBA Originally appeared in ASDS Currents Magazine (American Society for Dermatologic Surgery) Download PDF In today’s competitive aesthetic and medical dermatology landscape, a strong social media presence isn’t just a bonus — it’s a business imperative. Yet, many dermatologists find themselves posting content that doesn’t resonate, wondering why engagement is low or
By Brandy Church, CEO of ImageBloom, Inc. Patient recruitment has always been a high-stakes, high-cost challenge. Sponsors often pour significant resources into recruitment efforts, only to face delays, low enrollment rates, and underwhelming returns. After over a decade in the industry including years at the site level, I’ve seen firsthand how avoidable inefficiencies drain both
